Corpus Intelligence IC Memo — AVERA ST MARYS 2026-04-26 06:42 UTC
IC Memo — AVERA ST MARYS
Investment Committee Memorandum | SD | 50 beds | Grade C | EBITDA uplift $7.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA ST MARYS

CCN 430015 | HUGHES, SD | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AVERA ST MARYS is a 50-bed rural/critical access in HUGHES, SD with $105.0M in net patient revenue and a -10.6% operating margin. The hospital serves a payer mix of 45.1% Medicare, 21.5% Medicaid, and 33.4% commercial.

Thesis: Turnaround. Our ML models identify $7.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.6% to -3.3% (+736bps).

Net Revenue HCRIS$105.0M
Current EBITDA COMPUTED$-11.1M
Operating Margin COMPUTED-10.6%
Occupancy HCRIS33.1%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS30.0%
Distress Probability ML55.6%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
31
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -10.6% places it below the state median. Among 31 size-comparable peers (25-100 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 31 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA ST MARYS (Target)SD50$105.0M-10.6%
AVERA ST. LUKESSD50$210.6M-7.3%
AVERA HEART HOSPITAL OF SOUTH SD53$139.0M1.5%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
PRAIRIE LAKES HEALTH CARE CENTSD69$123.9M-9.8%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.2M+210bp18mo
Cost to Collect4.5%2.5%$2.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$67K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.2M
Cost to Collect
$2.1M
Denial Rate Reduction
$2.1M
A/R Days Reduction
$1.3M
Clean Claim Rate
$67K
Total EBITDA Uplift$7.7M
Current EBITDA$-11.1M
+ RCM Uplift+$7.7M
Pro Forma EBITDA$-3.4M
Current Margin-10.6%
Pro Forma Margin-3.3%
WC Released (1x)$4.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-17.2M$3.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-17.2M$-1.4M0.00x-100.0%
Bull Case9.0x11.0x$-15.4M$18.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-15.4M$15.6M0.00x-100.0%
Bear Case11.0x10.0x$-18.9M$-29.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-18.9M$-38.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 31 hospitals with 25-100 beds
  • Same-state prioritization (n=32)
  • Comp margins: P25=-7.4% / P50=-3.1% / P75=8.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.